English

HONGKONG XINCHENG GONGCHUANG TECHNOLOGY CO., LTD.

HONGKONG XINCHENG GONGCHUANG TECHNOLOGY CO., LTD.

Home > Products > Raw Steroid Powders > 99% Pure Idebenone Powder Idbn Nootropic Raw Steroid Powders CAS 58186-27-9
 

99% Pure Idebenone Powder Idbn Nootropic Raw Steroid Powders CAS 58186-27-9

  • 99% Pure Idebenone Powder Idbn Nootropic Raw Steroid Powders CAS 58186-27-9
Place of Origin:
China
Brand Name:
HBYC
Certification:
ISO 9000, SGS
Model Number:

HBYC

Min.Order Quantity:
10gram
Price:
negotiable(best offer will be provided)
Packaging Details:
designed disguised packing ways, 100% pass custom guarantee)
Delivery Time:
within 24hours after payment confirm
Payment Terms:
T/T, Western Union, MoneyGram,Bitcoin
Supply Ability:
1000Kg per Month
Contact Now
 

Product Description

Idebenone


99% Pure Idebenone Powder Idbn Nootropic CAS 58186-27-9 Stimulants Drugs
Cognition Enhancer 99% Idebenone Powder 58186-27-9 for Nootropic Drugs

Idebenone
Product name:Idebenone
Other name:Idebenone
Idebenone CAS No:58186-27-9
Idebenone Molecular formula:C19H30O5
Idebenone Molecular weight:338.44
Idebenone EINECS:N/A
Idebenone Assay:99% min pure
Idebenone Appearance: orange-yellow crystalline powder
Catalogue:Pharmaceutical materials;Health supplements;APIs;Brain health drug;Nootropic
Other Nootropics we offer:noopept;hydroxypiracetam;piracetam;Ferulic Acid;COLURACETAM

What is Idebenone


Idebenone (pronounced eye-deb-eh-known, trade names Catena, Raxone, Sovrima, among others) is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimers disease and other cognitive defects.This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases

Idebenone are used for:


Nootropic effects and Alzheimers disease


Idebenone improved learning and memory in experiments with mice.In humans, evaluation of Surrogate endpoints like electroretinography, auditory evoked potentials and visual analogue scales also suggested positive nootropic effects, but larger studies with hard endpoints are missing.
Friedreichs ataxia (Sovrima)
Preliminary testing has been done in humans and found idebenone to be a safe treatment for Friedreichs ataxia (FA), exhibiting a positive effect on cardiac hypertrophy and neurological function.The latter was only significantly improved in young patients.[9] In a different experiment, a one-year test on eight patients, idebenone reduced the rate of deterioration of cardiac function, but without halting the progression of ataxia.


Other neuromuscular diseases


Phase I and II clinical trials for the treatment of MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) and primary progressive multiple sclerosis are ongoing as of December 2013.

Pharmacokinetics of Idebenone
Idebenone is well absorbed from the gut but undergoes excessive first pass metabolism in the liver, so that less than 1% reach the circulation. This rate can be improved with special formulations (suspensions) of idebenone and by administering it together with fat food; but even taking these measures bioavailability still seems to be considerably less than 14% in humans. More than 99% of the circulating drug are bound to plasma proteins. Idebenone metabolites include glucuronides and sulfates, which are mainly (~80%) excreted via the urine.


99% Pure Idebenone Powder Idbn Nootropic Raw Steroid Powders CAS 58186-27-9 Images

 

Send Inquiry

*Email

Please Enter your Email Address

Subject

Inquiry About

Quick question
Please select FAQ

I'm very interested in your products; could you send me some detail reference information?

Please send me detail product specification, thank you!

May I be an agency of your products,and what's yourterms?

We intend to purchase this product, would you please send me the quotation and minimum order quantity?

*Message
I want to buy

For the best results, we recommend including the following details: -Self introduction -Required specifications -Inquire about price/MOQ